Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPO | P05164 | 8/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18563879 | 0.98 | MPO (0.43) | MPOSLC6A4TAAR1MGLLHTR1A | |
| SCHEMBL16521079 | 0.98 | MPO (0.43) | MPOSLC6A4TAAR1MGLLHTR1A | |
| SCHEMBL18198906 | 0.98 | MPO (0.43) | MPOSLC6A4TAAR1MGLLHTR1A | |
| SCHEMBL15942683 | 0.98 | MPO (0.43) | MPOSLC6A4TAAR1MGLLHTR1A | |
| SCHEMBL16521080 | 0.98 | MPO (0.43) | MPOSLC6A4TAAR1MGLLHTR1A | |
| SCHEMBL18134209 | 0.98 | MPO (0.43) | MPOSLC6A4TAAR1MGLLHTR1A | |
| SCHEMBL15396384 | 0.94 | HTR1A (0.43) | MPOSLC6A4TAAR1MGLLHTR1A | |
| SCHEMBL8611487 | 0.94 | MPO (0.40) | MPOSLC6A4TAAR1MGLLHTR1A | |
| SCHEMBL6684267 | 0.93 | MPO (0.46) | MPOSLC6A4TAAR1MGLLHTR1A | |
| SCHEMBL12574831 | 0.90 | MPO (0.44) | MPOSLC6A4TAAR1MGLLHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240026074-A1 | Polycarbonate Compositions Containing Titanium Dioxide and Glass Flakes Comprising a Titanium Dioxide Coating | COVESTRO DEUTSCHLAND AG (DE) | 2024-01-25 | — | — | US | disclosed |
| US-20240026074-A1 | Polycarbonate Compositions Containing Titanium Dioxide and Glass Flakes Comprising a Titanium Dioxide Coating | COVESTRO DEUTSCHLAND AG (DE) | 2024-01-25 | — | — | US | disclosed |
| US-11795323-B2 | Polycarbonate composition comprising talc | COVESTRO DEUTSCHLAND AG (DE) | 2023-10-24 | — | — | US | disclosed |
| US-11795323-B2 | Polycarbonate composition comprising talc | COVESTRO DEUTSCHLAND AG (DE) | 2023-10-24 | — | — | US | disclosed |
| US-11708455-B2 | Flame-retardant polycarbonate composition | COVESTRO DEUTSCHLAND AG (DE) | 2023-07-25 | — | — | US | disclosed |
| US-20230167296-A1 | FLAME-RETARDANT POLYCARBONATE COMPOSITION | COVESTRO DEUTSCHLAND AG (DE) | 2023-06-01 | — | — | US | disclosed |
| US-20230125361-A1 | FLAME-RETARDANT POLYCARBONATE COMPOSITION | COVESTRO DEUTSCHLAND AG (DE) | 2023-04-27 | — | — | US | disclosed |
| US-9557645-B2 | Positive photosensitive resin composition, photo-curable dry film and method for producing same, layered product, patterning process, and substrate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-01-31 | — | — | US | disclosed |
| US-9512276-B2 | Phenol-modified polyorganosiloxane with reduced platinum content, method for preparing the same, and modifier for organic resin containing the same | DOW CORNING TORAY CO., LTD. (JP) | 2016-12-06 | — | — | US | disclosed |
| US-9400428-B2 | Polymer compound, chemically amplified negative resist composition, photo-curable dry film and production method thereof, layered product, patterning process, and substrate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-07-26 | — | — | US | disclosed |
| US-20100140537-A1 | Curable Silicone Composition | DOW CORNING TORAY CO., LTD. (JP) | 2010-06-10 | — | — | US | disclosed |
| US-20100113667-A1 | Curable Silicone Composition and Electronic Component | DOW CORNING TORAY COMPANY, LTD. (JP) | 2010-05-06 | — | — | US | disclosed |
| US-20100063185-A1 | Curable Silicone Composition and Electronic Component | DOW TORAY CO., LTD. (JP) | 2010-03-11 | — | — | US | disclosed |
| US-20100022704-A1 | Curable Silicone Composition And Cured Body Thereof | DOW CORNING TORAY COMPANY, LTD. (JP) | 2010-01-28 | — | — | US | disclosed |
| US-20090247681-A1 | Curable Silicone Composition And Cured Product Therefrom | DOW CORNING TORAY COMPANY, LTD. (JP) | 2009-10-01 | — | — | US | disclosed |
| US-20090234078-A1 | Organotrisiloxane, Preparation And Use In Curable Resin Composition | DOW CORNING TORAY COMPANY, LTD. (JP) | 2009-09-17 | — | — | US | disclosed |
| US-20090214870-A1 | Curable Silicone Composition And Electronic Device Produced Therefrom | DOW CORNING TORAY COMPANY, LTD. (JP) | 2009-08-27 | — | — | US | disclosed |
| US-20090203837-A1 | Curable Silicone Composition And Electronic Components | DOW CORNING TORAY COMPANY, LTD. (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20080308225-A1 | Adhesive composition suitable to be applied by screen printing | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2008-12-18 | — | — | US | disclosed |
| US-20080265439-A1 | Die bonding agent and a semiconductor device made by using the same | SHIN-ETSU CHEMICAL CO., LTD. | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090234078-A1 | Organotrisiloxane, Preparation And Use In Curable Resin Composition | SEM1, CECR2, HRH3 | MPO 1490/4885SLC6A4 4031/4885TAAR1 1381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.